Selventa Raises $5M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life science data analysis firm Selventa has raised $5 million in an equity round, it disclosed in a document filed with the US Securities and Exchange Commission this week.

The company did not say how the funds would be used and did not disclose participants in the financing, though it said nine people invested in the round.

A company official was not available for comment, a spokesperson said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.